GlassScriptPhysician profile
Lea Meir
NPI 1639673395
$2,527.50
in general payments reported to CMS, 2019-2025
17 companies · $1,864 in 2025
The $1,864 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $663 · 2025: $1,864.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,428 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,427.51 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $522.97 | 2024-2025 | |
| Mallinckrodt Hospital Products INC. | $455.18 | 2024-2025 | Acthar |
| Janssen Biotech, INC. | $384.84 | 2025 | Tremfya, Simponi Aria |
| Ucb, INC. | $241.63 | 2024-2025 | Bimzelx, Cimzia |
| Pfizer INC. | $228.22 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $221.45 | 2024-2025 | |
| Ani Pharmaceuticals, INC. | $87.21 | 2024 | Purified Cortrophin Gel |
| Aurinia Pharma U.S., INC. | $68.25 | 2024-2025 | Lupkynis |
| Amgen INC. | $53.46 | 2024-2025 | Krystexxa, Uplizna |
| Astrazeneca Pharmaceuticals LP | $50.49 | 2024 | Saphnelo |
| Organon LLC | $50.12 | 2024-2025 | Hadlima |
| Glaxosmithkline, LLC. | $41.98 | 2025 | Benlysta |
| Alexion Pharmaceuticals, INC. | $29.06 | 2025 | Strensiq |
| E.R. Squibb & Sons, L.L.C. | $27.07 | 2025 | Orencia |
| Radius Health, INC. | $23.44 | 2025 | Tymlos |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $23.35 | 2025 | |
| Fidia Pharma USA INC. | $18.78 | 2025 | Triluron, Hymovis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lea Meir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.